Cardio Diagnostics Holdings, Inc. (CDIO)
1.80
-0.07
(-3.74%)
USD |
NASDAQ |
Oct 12, 14:17
Cardio Diagnostics Holdings Free Cash Flow (Quarterly) : -1.389M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.389M |
| March 31, 2026 | -1.626M |
| December 31, 2025 | -1.440M |
| September 30, 2025 | -1.651M |
| June 30, 2025 | -1.607M |
| March 31, 2025 | -1.448M |
| December 31, 2024 | -1.447M |
| September 30, 2024 | -1.236M |
| June 30, 2024 | -1.412M |
| March 31, 2024 | -1.303M |
| Date | Value |
|---|---|
| December 31, 2023 | -2.253M |
| September 30, 2023 | -1.110M |
| June 30, 2023 | -1.380M |
| March 31, 2023 | -1.702M |
| December 31, 2022 | -3.127M |
| September 30, 2022 | -1.421M |
| June 30, 2022 | -0.417M |
| March 31, 2022 | -0.2025M |
| December 31, 2021 | -0.6991M |
| September 30, 2021 | 0.0356M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -14.15M |
| Exicure, Inc. | -0.887M |
| Century Therapeutics, Inc. | -20.53M |
| Absci Corp. | -27.56M |
| Celularity, Inc. | 1.447M |